University of Wisconsin–Madison

A Placebo-Controlled, Double-Blind, Parallel-Group, 24-Month Study to evaluate the efficacy and safety of E2609 in subjects with Early Alzheimer’s Disease

June 2017 to January 2020

This project led by: Sanjay Asthana MD